AP
IBB icon

Appleton Partners’s iShares Biotechnology ETF IBB Stock Holding History

Appleton Partners’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.3M Buy
75,359
+1,349
+2% +$232K 0.88% 32
2026
Q1 		$12.5M Buy
74,010
+110
+0.1% +$18.8K 0.87% 32
2025
Q4 		$12.5M Sell
73,900
-13
-0% -$2.11K 0.82% 38
2025
Q3 		$10.7M Buy
73,913
+19
+0% +$2.59K 0.72% 47
2025
Q2 		$9.35M Sell
73,894
-4,488
-6% -$551K 0.66% 54
2025
Q1 		$10M Buy
78,382
+2,579
+3% +$350K 0.77% 45
2024
Q4 		$10M Buy
75,803
+104
+0.1% +$14.6K 0.74% 48
2024
Q3 		$11M Buy
75,699
+2,032
+3% +$294K 0.81% 41
2024
Q2 		$10.1M Buy
73,667
+735
+1% +$98.1K 0.78% 41
2024
Q1 		$10M Buy
72,932
+870
+1% +$119K 0.78% 43
2023
Q4 		$9.79M Buy
72,062
+2,136
+3% +$261K 0.79% 38
2023
Q3 		$8.55M Buy
69,926
+5,308
+8% +$675K 0.76% 36
2023
Q2 		$8.2M Buy
64,618
+2,264
+4% +$294K 0.69% 43
2023
Q1 		$8.05M Buy
62,354
+4,803
+8% +$629K 0.72% 37
2022
Q4 		$7.56M Buy
57,551
+627
+1% +$81K 0.72% 36
2022
Q3 		$6.66M Sell
56,924
-1,267
-2% -$157K 0.67% 40
2022
Q2 		$6.84M Sell
58,191
-2,710
-4% -$322K 0.65% 46
2022
Q1 		$7.93M Sell
60,901
-1,227
-2% -$160K 0.65% 48
2021
Q4 		$9.48M Buy
62,128
+853
+1% +$132K 0.71% 40
2021
Q3 		$9.91M Buy
61,275
+1,566
+3% +$264K 0.83% 37
2021
Q2 		$9.77M Buy
59,709
+4,706
+9% +$725K 0.83% 34
2021
Q1 		$8.28M Buy
55,003
+4,059
+8% +$645K 0.77% 34
2020
Q4 		$7.72M Buy
50,944
+323
+0.6% +$46.2K 0.76% 36
2020
Q3 		$6.86M Sell
50,621
-147
-0.3% -$19.9K 0.76% 34
2020
Q2 		$6.94M Sell
50,768
-848
-2% -$108K 0.83% 34
2020
Q1 		$5.56M Sell
51,616
-1,146
-2% -$132K 0.77% 35
2019
Q4 		$6.36M Sell
52,762
-640
-1% -$71.4K 0.7% 41
2019
Q3 		$5.31M Sell
53,402
-912
-2% -$95.5K 0.64% 41
2019
Q2 		$5.93M Buy
54,314
+220
+0.4% +$23.4K 0.73% 38
2019
Q1 		$6.05M Buy
54,094
+365
+0.7% +$40K 0.8% 35
2018
Q4 		$5.18M Sell
53,729
-405
-0.7% -$43K 0.78% 40
2018
Q3 		$6.6M Sell
54,134
-700
-1% -$82.4K 0.88% 32
2018
Q2 		$6.02M Buy
54,834
+690
+1% +$73.8K 0.86% 35
2018
Q1 		$5.78M Buy
54,144
+515
+1% +$57.1K 0.88% 35
2017
Q4 		$5.73M Buy
53,629
+406
+0.8% +$43.4K 0.89% 32
2017
Q3 		$5.92M Buy
53,223
+9
+0% +$962 1% 26
2017
Q2 		$5.5M Sell
53,214
-768
-1% -$75.6K 0.92% 31
2017
Q1 		$5.28M Sell
53,982
-3,645
-6% -$349K 0.97% 31
2016
Q4 		$5.1M Sell
57,627
-4,518
-7% -$411K 1.03% 32
2016
Q3 		$6M Sell
62,145
-1,815
-3% -$173K 1.13% 31
2016
Q2 		$5.49M Sell
63,960
-14,124
-18% -$1.27M 1.12% 32
2016
Q1 		$6.79M Sell
78,084
-3,342
-4% -$299K 1.34% 24
2015
Q4 		$9.18M Buy
81,426
+525
+0.6% +$57K 1.81% 8
2015
Q3 		$8.18M Sell
80,901
-3,513
-4% -$421K 1.86% 9
2015
Q2 		$10.4M Sell
84,414
-1,323
-2% -$158K 2.33% 5
2015
Q1 		$9.81M Buy
85,737
+1,530
+2% +$169K 2.21% 5
2014
Q4 		$8.52M Sell
84,207
-168
-0.2% -$16.3K 1.95% 8
2014
Q3 		$7.7M Sell
84,375
-1,290
-2% -$113K 1.8% 12
2014
Q2 		$7.34M Sell
85,665
-939
-1% -$74K 1.72% 15
2014
Q1 		$6.82M Buy
86,604
+2,169
+3% +$181K 1.61% 18
2013
Q4 		$6.39M Buy
84,435
+2,925
+4% +$208K 1.53% 25
2013
Q3 		$5.7M Buy
81,510
+1,035
+1% +$67.8K 1.53% 25
2013
Q2 		$4.66M Buy
+80,475
New +$4.65M 1.34% 32

Other funds holding IBB

WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $1.92B AUM 25.81% 1-Year Est. Return
FMI
Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return
CA
Cumberland Advisors Sarasota, Florida $284M AUM 27.11% 1-Year Est. Return
FNFDCM
Folger Nolan Fleming Douglas Capital Management Washington, District of Columbia $1.22B AUM 34.81% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
RFA
Reyes Financial Architecture San Diego, California $179M AUM 31.17% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Appleton Partners's IBB Position: Q2 2026 in Review

Appleton Partners increased its iShares Biotechnology ETF (IBB) stake by 1.8% in Q2 2026, buying an estimated $232K and bringing the position to 75,359 shares worth $14.3M. The position accounts for 0.88% of the portfolio, ranked #32.

Appleton Partners first reported a position in IBB in Q2 2013 and has held it in 53 quarters since. 211 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Appleton Partners held 75,359 shares of iShares Biotechnology ETF worth $14.3M as of Q2 2026.
  • Appleton Partners bought 1,349 iShares Biotechnology ETF shares in Q2 2026, an estimated $232K.
  • iShares Biotechnology ETF made up 0.88% of Appleton Partners's portfolio in Q2 2026, its #32 holding.
  • Appleton Partners first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 53 quarters since.
  • 211 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Appleton Partners's 13F filing for Q2 2026, filed 21 Jul 2026.